Correction to: Theranostic role of 89Zr‑ and 177Lu‑labeled aflibercept in breast cancer
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
European journal of nuclear medicine and molecular imaging - 51(2024), 5 vom: 12. Jan., Seite 1495-1495 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yang, Qi [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024 |
|---|
| doi: |
10.1007/s00259-023-06590-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055234089 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055234089 | ||
| 003 | DE-627 | ||
| 005 | 20240322064641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-023-06590-w |2 doi | |
| 035 | |a (DE-627)SPR055234089 | ||
| 035 | |a (SPR)s00259-023-06590-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.64 |2 bkl | ||
| 100 | 1 | |a Yang, Qi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to: Theranostic role of 89Zr‑ and 177Lu‑labeled aflibercept in breast cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024 | ||
| 700 | 1 | |a Chen, Zhao |4 aut | |
| 700 | 1 | |a Qiu, Yongkang |4 aut | |
| 700 | 1 | |a Huang, Wenpeng |4 aut | |
| 700 | 1 | |a Wang, Tianyao |4 aut | |
| 700 | 1 | |a Song, Lele |4 aut | |
| 700 | 1 | |a Sun, Xinyao |4 aut | |
| 700 | 1 | |a Li, Cuicui |4 aut | |
| 700 | 1 | |a Xu, Xiaojie |4 aut | |
| 700 | 1 | |a Kang, Lei |0 (orcid)0000-0001-8729-4547 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Springer Berlin Heidelberg, 2002 |g 51(2024), 5 vom: 12. Jan., Seite 1495-1495 |w (DE-627)SPR003104508 |w (DE-600)2098375-X |x 1619-7089 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2024 |g number:5 |g day:12 |g month:01 |g pages:1495-1495 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00259-023-06590-w |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.64 |q VZ |
| 951 | |a AR | ||
| 952 | |d 51 |j 2024 |e 5 |b 12 |c 01 |h 1495-1495 | ||